Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era
- PMID: 17680849
- DOI: 10.1111/j.1572-0241.2007.01435.x
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era
Abstract
Objectives: Corticosteroids are a cornerstone in the treatment of a severe attack of ulcerative colitis (UC). The long-term prognosis in this patient group is not well described. We studied the long-term colectomy and relapse rates in patients given intensive intravenous corticosteroid treatment (IIVT) for acute UC.
Methods: A retrospective clinical study of 158 patients with UC treated in 1975-1982 with IIVT. Patients were followed-up to death, colectomy or last visit.
Results: A total of 11 patients were excluded due to change of diagnosis (N = 10) or lost to follow-up (N = 1). The indication for index IIVT in the remaining 147 patients was a severe attack (N = 61), a moderately severe attack (N = 45), a mild attack (N = 29) or chronic continuous disease (N = 12). The median (range) duration of follow-up was 173 (4-271) months in patients escaping colectomy during the first 3 months. Three months after IIVT, the colectomy rates were 28/61 (46%) in a severe attack, 4/45 (9%) in a moderately severe, and 1/29 (3%) in a mild attack. After 10 yr, the colectomy rates were 39/61 (64%), 22/45 (49%), and 8/29 (28%), respectively. During follow-up, neither colectomy incidence beyond 3 months, time to first relapse nor relapse incidence was influenced by severity of initial attack, except for a lower relapse incidence after a severe attack.
Conclusions: In patients escaping colectomy during the first 3 months after IIVT, the future prognosis was similar irrespective of initial disease severity.
Similar articles
-
Colectomy rate in acute severe ulcerative colitis in the infliximab era.Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9. Dig Liver Dis. 2008. PMID: 18472316
-
Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.Z Gastroenterol. 1998 Apr;36(4):287-93. Z Gastroenterol. 1998. PMID: 9612926
-
Outcome of a conservative approach in severe ulcerative colitis.Dig Liver Dis. 2004 Jan;36(1):21-8. doi: 10.1016/j.dld.2003.04.001. Dig Liver Dis. 2004. PMID: 14971812
-
Current management of severe ulcerative colitis.Nat Clin Pract Gastroenterol Hepatol. 2007 Feb;4(2):92-101. doi: 10.1038/ncpgasthep0687. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17268544 Review.
-
[Management of severe attack of ulcerative colitis].Lakartidningen. 2009 Nov 4-12;106(45):2994-8. Lakartidningen. 2009. PMID: 19998825 Review. Swedish. No abstract available.
Cited by
-
Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.Medicine (Baltimore). 2018 Aug;97(32):e11440. doi: 10.1097/MD.0000000000011440. Medicine (Baltimore). 2018. PMID: 30095612 Free PMC article. Review.
-
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.United European Gastroenterol J. 2021 May;9(4):507-516. doi: 10.1177/2050640620977405. Epub 2021 Feb 16. United European Gastroenterol J. 2021. PMID: 33259773 Free PMC article.
-
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.Dig Dis Sci. 2022 Aug;67(8):3984-3992. doi: 10.1007/s10620-021-07233-6. Epub 2021 Aug 30. Dig Dis Sci. 2022. PMID: 34460029 Free PMC article. Clinical Trial.
-
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study.Intest Res. 2022 Jan;20(1):64-71. doi: 10.5217/ir.2020.00100. Epub 2021 Feb 3. Intest Res. 2022. PMID: 33525859 Free PMC article.
-
Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study.BMJ Open. 2012 Apr 5;2(2):e000823. doi: 10.1136/bmjopen-2012-000823. Print 2012. BMJ Open. 2012. PMID: 22492386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical